1. Introduction

Marine Drugs

1660-3397

Molecular Diversity Preservation International

10.3390/md8020313

marinedrugs-08-00313

Review

Bioactive Sesterterpenes and Triterpenes from Marine Sponges: Occurrence and Pharmacological Significance

Ebada

Sherif S.

13* Lin

WenHan

2 Proksch

Peter

1 Institute of Pharmaceutical Biology and Biotechnology, Heinrich-Heine University, Universitaetsstrasse 1, D-40225 Duesseldorf, Germany 2 State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100083, China; E-Mail: whlin@bjmu.edu.cn 3 Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Ain-Shams University, Abbasia, Cairo, Egypt

*Authors to whom correspondence should be addressed; sherif.Elsayed@uni-duesseldorf.de (S.S.E.); proksch@uni-duesseldorf.de (P.P.); Tel.: +49-211-81-14163; Fax: +49-211-81-11923.

2010

23 2 2010

8 2 313 346 20 1 2010 5 2 2010 20 2 2010

2010

This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).

Marine ecosystems (>70% of the planet’s surface) comprise a continuous resource of immeasurable biological activities and immense chemical entities. This diversity has provided a unique source of chemical compounds with potential bioactivities that could lead to potential new drug candidates. Many marine-living organisms are soft bodied and/or sessile. Consequently, they have developed toxic secondary metabolites or obtained them from microorganisms to defend themselves against predators [1]. For the last 30–40 years, marine invertebrates have been an attractive research topic for scientists all over the world. A relatively small number of marine plants, animals and microbes have yielded more than 15,000 natural products including numerous compounds with potential pharmaceutical potential. Some of these have already been launched on the pharmaceutical market such as Prialt^® (ziconotide; potent analgesic) and Yondelis^® (trabectedin or ET-743; antitumor) while others have entered clinical trials, e.g., alpidin and kahalalide F. Amongst the vast array of marine natural products, the terpenoids are one of the more commonly reported and discovered to date. Sesterterpenoids (C₂₅) and triterpenoids (C₃₀) are of frequent occurrence, particularly in marine sponges, and they show prominent bioactivities. In this review, we survey sesterterpenoids and triterpenoids obtained from marine sponges and highlight their bioactivities.

sesterterpenoids triterpenoids marine sponges

1. Introduction

Terpenes include primary and secondary metabolites, all biosynthesized from the five carbon isoprene building units [2]. Structural modification of these isoprene units leads a massively diverse range of derivatives with a wide array of chemical structures and biological properties. While higher plants’ terpenoids were already studied and ethnopharmacologically rationalized centuries ago, those from marine counterparts were not explored until the first half of the 20^th century.

Steroidal terpenoids were the first marine isoprenes to be discovered by Bergmann during the 1930s–1940s, particularly sterols that were obtained from various marine macroorganisms [3]. Secondary metabolites, including terpenes, play an important ecological role in marine organisms. Being sessile and soft bodied, marine organisms face a harsh competition for space, reproduction, maintenance of an unfouled surface and deterrence of predation [4]. Therefore, marine organisms have developed bioactive secondary metabolites as a potential defensive means against competitors and/or predators [1]. These compounds are rapidly diluted after being released into the water and hence have to be of outstanding potency to retain their efficacy. These bioactivity(ies) proved appealing for chemical ecologists as well as for pharmacologists in their search for new drugs to treat or cure serious ailments such as inflammatory, infectious and cancerous diseases.

Marine terpenoids dominate much of the literature expression with a huge number of derivatives having been obtained from marine resources. It seems pointless to compile a review that includes all major classes of marine terpenoids. Therefore, in this review we concentrate on two major classes of marine isoprenes from sponges, namely the sesterterpenoids (C₂₅) and triterpenoids (C₃₀) with particular attention placed on their biological activities.

Marine triterpenoids were the first terpenoids reported from marine resources and since then a vast array of derivatives have been documented. In this review, we cover steroidal saponins and isomalabaricane triterpenoids. In addition, marine sponges have been identified as one of the prime resources of sesterterpenes and hence we also survey this class of marine terpenoids.

2. Sesterterpenes (C<sub>25</sub>)

Manoalide (1) is the parent compound of a series of marine sponge metabolites belonging to the sesterterpene class. Manoalide was first reported in 1980 by Scheuer from the marine sponge Luffariella variabilis (class Demospongiae; order Dictyoceratida; family Thorectidae) collected in Palau [5] with activity as an antibiotic against Streptomyces pyogenes and Staphylococcus aureus.

One year later, Scheuer reported three additional related metabolites from the same Palauan sponge, namely secomanoalide (2), (E)-neomanoalide (3) and (Z)-neomanoalide (4) [6]. All three compounds, as well as the parent compound (1), displayed antibacterial activity against Gram positive bacteria (Staphylococcus aureus and Bacillus subtilis) but were inactive against Escherichia coli, Pseudomonas aeruginosa and Candida albicans [6].

Later, marine sponges belonging to the family Thorectidae, including species of the genera Luffariella [7–19], Hyrtios [20,21], Thorectandra [22], Cacospongia [23,24], Fasciospongia [25–28], Acanthodendrilla [29] and Aplysinopsis [30], were also found to be rich sources of novel bioactive sesterterpenoids related to manoalide.

Manoalide was further investigated and found to be a potent inhibitor of phospholipase A₂ (PLA₂) [31–38]. Subsequently, many structurally related metabolites with PLA₂ inhibitory activity were also reported [8, 39–45]. PLA₂ is an enzyme that specifically catalyzes the hydrolysis of phospholipids at the S_N-2 position to produce a lysophospholipid and arachidonic acid, which in turn provides the substrate for proinflammatory mediators such as leukotrienes, prostaglandins and thromboxanes, collectively known as the eicosanoids [41]. Since manoalide revealed an irreversible inhibition of phospholipase A₂ (PLA₂) [33], the structure-activity relationships (SAR) of this compound attracted scientific interests to study and to understand both PLA₂ function and mechanism of action in the whole cell. Therefore, several studies were successfully performed to determine the contributions of the various functional groups incorporated in 1 and its analogs, such as the γ-hydroxybutenolide, α-hydroxydihydropyran and trimethylcyclohexenyl ring systems, to the efficacy as PLA₂ inhibitors [36,41,45]. These studies indicated that (1) the existence of the hemiacetal in the α-hydroxydihydropyran ring is crucial for irreversible binding, (2) the γ-hydroxybutenolide ring is involved in the initial interaction with PLA₂ and (3) the hydrophobic nature of the trimethylcyclohexenyl ring system allows non-bonded interactions with the enzyme that enhances the potency of these analogs. These studies suggested that the closed ring form of manoalide is the predominant molecular moiety that accounts for the selective and potent inhibition of PLA₂ [36].

Manoalide analogs also exhibited other bioactivities including molluscicidal [10], cytotoxicity [13,14,16,20,23,26,29,30,47–49], inhibitory activity of Cdc25 phosphatase [46], nicotinic antagonistic activity [12] and fish deterrent properties [26,49]. Therefore, chemical synthesis and derivatization of manoalide attracted much interest leading to a better understanding of the structure activity relationships (SAR) and/or for the plausible mechanism of action [35,38–40,43,44,50,51]. Manoalide (1) was licensed to Allergan Pharmaceuticals and reached phase II clinical trials as a topical antipsoriatic. Its development was, however, discontinued due to formulation problems. The compound is now commercially available as a biochemical standard tool to block the action of PLA₂ [52].

Luffariellolide (5) is a sesterterpenoid analog of secomanoalide (2), which was first reported from a Palauan sponge Luffariella sp. [8]. Structurally, luffariellolide differed in having C-24 as methyl group instead of an aldehyde functionality as in 2 and it was obtained as the (Z) isomer as well.

In contrast to the irreversible inhibitory action of manoalide (1) towards PLA₂, luffariellolide (5) is a slightly less potent, but a partially reversible inhibitor. This meant that 5 became a more preferable anti-inflammatory agent for potential pharmacological investigation [8].

In addition to luffariellolide (5), its 25-O-methyl (6) and 25-O-ethyl derivatives (7), five related sesterterpenes, acantholides A–E, were obtained from the Indonesian sponge Acanthodendrilla sp. [29]. Acantholide D (8) and E (9) represent rare variants for the C₁₄–C₂₀ segment in this type of linear sesterterpenes in which they have the 1-acetylcyclopentan-5-ol moiety replacing the trimethylcyclohexenyl ring. Luffariellolide (5) and its 25-O-methyl congener (6), as well as acantholide E (9), were cytotoxic against the mouse lymphoma L5178Y cell line with IC₅₀ values of 8.5, 1.8, and 16.8 μM, respectively. Interestingly, these results suggest that the 25-O-methyl group in 6 and the stereochemistry of 1-acetylcyclopentan-5-ol in 9 play an important role [29].

Luffariolides A–J represent a related group of sesterterpenoidal analogs, which have been obtained from different collections of the Okinawan marine sponge Luffariella sp. [13,14,16].

All luffariolides exhibited significant cytotoxicity against murine lymphoma L1210 cells with IC₅₀ values ranging between 2.9–19.3 μM. Amongst them, luffariolides A (10, IC₅₀ 2.9 μM), B (11, IC₅₀ 3.23 μM), E (12, IC₅₀ 3.0 μM) and F (13, IC₅₀ 3.8 μM) were the most active ones [13,14,16].

Luffariellins A (14) and B (15) [7] together with their respective 25-acetoxy derivatives (18 and 19) [18] were isolated from the marine sponge Luffariella variabilis collected off different locations in Palau and in Australia, whereas luffariellins C (16) and D (17) were obtained from the shell-less marine mollusc Chromodoris funerea collected from the Kaibakku lake shores in Palau [53].

Luffariellins (14–19) are all characterized by the 1-isoproprenyl-2-methylcyclopentane ring system replacing the trimethylcyclohexenyl moiety in other manoalide analogs. Despite this discrepancy in chemical structure, luffariellins A (14) and B (15) retain identical functional groups as present in manoalide (1) and secomanoalide (2), respectively. Therefore, not surprisingly each respective pair was shown to have similar anti-inflammatory properties to 1 and 2 [7].

Luffarin metabolites comprise another group of compounds represented by 28 derivatives. 26 of them, luffarins A–Z, have been reported from the Australian marine sponge Luffariella geometrica [12], while the other two were obtained from the Adriatic Sea sponge Fasciospongia cavernosa [28]. Based on the chemical structures, luffarins have been classified into 14 bicyclic sesterterpenes, luffarins A–N; one bicyclic bisnorsesterterpene, luffarin O; one monocyclic sesterterpene, luffarin P; and six acyclic sesterterpenes, luffarin Q–V, in addition to four diterpenoidal derivatives, luffarin W–Z [12].

All luffarins were tested for antimicrobial activity against Staphylococcus aureus, Micrococcus sp., and Saccharomyces cerevisiae. Only luffarins C–F (22–25), K (26) and L (27) showed activity against both S. aureus and Micrococcus sp. [12], whereas luffarins A (20) and M (28) revealed only mild activity against the latter. Moreover, some luffarins were also found to be effective inhibitors of nicotinic receptors [12].

Biosynthetically, a relationship could be recognized between the various luffarins as illustrated in Figure 1. Luffarins appear to belong to the same enantiomeric series as reported for manoalide-type marine natural products. It is also curious to note that no acyclic luffarins incorporated the hydroxylated butenolide functionality. Perhaps the most interesting luffarins from a biosynthetic point of view are luffarins B (21) and O (21a), which were the first examples of a hitherto unknown cyclization pattern in compounds of this class [12].

Another example of bicyclic sesterterpenes are thorectandrols A–E (31–35) that were isolated from a Palauan collection of the marine sponge Thorectandra sp. [47,48] together with the parent compounds of this group palauolide (29) and palauolol (30). Palauolide (29) was obtained first as an antimicrobial sesterterpene from a three sponge association collected in Palau [54]. While palauolol (30) was identified as an anti-inflammatory sesterterpene from the Palauan sponge Fascaplysinopsis sp. and chemically it was recognized as being a secondary alcohol that upon dehydration yields 29 [55].

All thorectandrols (31–35) in addition to palauolide (29) and palauolol (30) were tested for antiproliferative activity against six to twelve human tumor cell lines depending on sample availability [48]. Palauolol (30) was active against all tested cell lines except A549 (non small lung cancer), with IC₅₀ values in the range 1.2–1.7 μM, while palauolide (29) showed a diminished activity. On the other hand, thorectandrols A–E revealed only weak to no cytotoxicity against the tested cell lines (IC₅₀’s 70–100 μM). While firm deductions on the structural requirements for activity were not possible, it appeared that the presence of both the hemiacetal lactone functionality and the 16-hydroxyl group in palauolol (30) enhanced cytotoxicity compared to palauolide (29) and other thorectandrols [48].

Cacospongionolides (36–40) were isolated from different collections of the marine sponge Fasciospongia cavernosa (=Cacospongia mollior) collected from the Mediterranean Sea [23,26,49,56]. Cacospongionolides A (36), B (37) and its 25-deoxy derivative (38) revealed a bicyclic sesterterpenoidal skeleton, resembling luffarins and thorectandrols, with the addition of a γ-hydroxybutenolide moiety. The other cacospongionolides C (39) and D (40) are acyclic diterpenoidal derivatives. Despite the structural relation with luffarins and thorectandrols, cacospongionolides (36–38) together with cacospongionolide D (40) exhibited significant cytotoxicity [23,26,49,56]. This notion suggested a possible relation between the presence of the γ-hydroxybutenolide moiety and the cytotoxicity.

Petrosaspongiolides A (41) and B (42) were the first cheilantane sesterterpene lactones to be isolated from a New Caledonian sponge incorrectly assigned to the genus Dactylospongia [57] and then reassigned as a new genus and a new species: Petrosaspongia nigra (Bergquist 1995 sp. nov., class Demospongiae; order Dictyoceratida; family Spongidae) [58].

From another New Caledonian collection of the same sponge, 15 additional petrosaspongiolide congeners (C–R) were isolated [59,60].

From the chloroform extract of another Dictyoceratida sponge of the genus Spongia, 21-hydroxy derivatives of petrosaspongiolides K (44a) and P (48a) were isolated in addition to four other pyridinium alkaloids named spongidines A–D (51–54) [61]. Spongidines were found to be structurally related to petrosaspongiolide L (45) particularly in the presence of pyridine ring.

Petrosaspongiolides A–L were subjected to in vitro cytotoxicity assay against the human bronchopulmonary NSCLC-N6 carcinoma cell line. They revealed IC₅₀ values ranging between 1.0–32.2 μM [59]. Petrosaspongiolides C (43) and K (44) exhibited the highest potency with IC₅₀ values of 1.0 and 3.5 μM, respectively. However, petrosaspongiolides A (41) and B (42) were the least cytotoxic congeners in vitro with IC₅₀ values of 28 and 32.2 μM, respectively, 41 inhibited tumoral proliferation in vivo at 20 mg/Kg without significant toxicity when tested on immunosuppressed rats carrying a bronchopulmonary tumor (NSCLC-N6) [59].

Petrosasponiolides M–R (46–50) revealed the presence of a γ-hydroxybutenolide moiety and a hemiacetal function. Due to these structural similarities to manoalide (1), petrosaspongiolides M–R have received special attention from the scientific community to study their inhibitory activity against PLA₂ from different resources to point out their specificity. Two main groups of PLA₂ enzymes have been reported [62], the secretory PLA₂ (sPLA₂ groups I, II, III, V, IX, and X with relatively small molecular weights) and the cytosolic PLA₂ (cPLA₂ groups IV, VI, VII, and VIII with higher molecular weights). Inhibition of specific PLA₂ constitutes a potentially useful approach for treating a wide variety of inflammatory disorders such as spetic shock, adult respiratory distress syndrome, arthritis, and acute pancreatitis [61].

Petrosaspongiolides M–R (46–50) together with 21-hydroxy derivatives of petrosaspongiolides K (44a) and P (48a), and spongidines A–D (51–54) were tested on five different sPLA₂s belonging to the groups I (Naja naja venom and porcine pancreatic enzymes), II (human synovial recombinant and rat air-pouch secretory enzymes), and III (bee venom enzyme) [60,61].

Among petrosaspongiolide derivatives, 46 and 48a inhibited mainly human synovial PLA₂ with IC₅₀ values of 1.6 and 5.8 μM, respectively, compared to manoalide (1) (IC₅₀ = 3.9 μM) [60,61]. Petrosaspongiolide M (46) also inhibited bee venom PLA₂ enzyme with IC₅₀ of 0.6 μM, compared to 1 (IC₅₀ of 7.5 μM) [60].

The mechanism of action of petrosaspongiolides M–R (46–50) as anti-inflammatory marine metabolites has been the topic for many research articles [63–68]. The covalent binding of 46 to bee venom PLA₂ has been investigated by mass spectrometry and molecular modeling. The mass increment observed was consistent with the formation of a Schiff base by reaction of a PLA₂ amino group with the hemiacetal function at the C-25 atom of the petrosaspongiolide M γ-hydroxybutenolide ring [63]. The molecular mechanism of inactivating the bee venom and the human type IIA secretory PLA₂s by petrosaspongiolides R (50) [67], and M (46) [68], respectively, has been investigated. In both cases, either covalent (imine formation) and/or non-covalent (van der Waals) interactions contributed to the inhibitory activity against PLA₂ enzymes [67,68]. Due to potent anti-inflammatory properties of petrosaspongiolides, their chemical synthesis has been interestingly investigated. Recently, the first enantioselective synthesis of petrosaspongiolide R (50) has been successfully performed [69].

3. Triterpenes (C<sub>30</sub>)

Steroidal triterpenes were the first marine isoprenes to be discovered in the 1930s. Scientific interest has been driven towards these metabolites due to the isolation of biosynthetically unprecedented derivatives possessing a broad spectrum of bioactivity(ies). Marine triterpenoids have been reported from various marine macroorganisms. In this section, we survey two examples of triterpenoidal metabolites namely isomalabaricane triterpenes and steroidal saponins obtained from marine sponges with particular attention being drawn to their pharmacological significance.

3.1. Isomalabaricane triterpenes

Malabaricol (55) is the chief triterpene constituent of a yellow pigment obtained from the wood of the terrestrial plant Ailanthus malabarica (family Simaroubaceae), after which the whole group of related compounds was named [70–72]. Malabaricane, the trivial name of this group of compounds, was given to the hydrocarbon system (3S^*,3aR^*,5aS^*,9aS^*,9bS^*)-3a,6,6,9a-tetramethyl-3-(1,5,9- trimethyldecyl)perhydr-obenz[e]indene, where the tricylic nucleus has a trans-anti-trans ring junction [71,72].

The malabaricanes are structurally characterized by a tricyclic triterpenoid core and a conjugated polyene side chain [70–72], whereas the isomalabaricane skeleton is embedded in a 4,4,8,10-tetramethyl-perhydrobenz[e]indene with a trans-syn-trans ring junction, that leads to an unfavorable twist-boat conformation for the central ring [73,74].

Isomalabaricane triterpenes were first reported from a Fijian collection of the sponge Jaspis stellifera [73] and the Somalian marine sponge Stelletta sp. [74]. Since then, they have been isolated from several genera of marine sponges belonging to the order Astrophorida including members of the genera Rhabdastrella [75,80,82,86,93,94,96,100], Stelletta [77–79,85,88,92], Jaspis [81,87,89,98,99,101,102], and Geodia [83,90,95].

Isomalabaricane triterpenoids having polyene conjugated functionality can be classified into three groups: (1) stelletins principally possessing the γ-pyrone functionality, which could be ring-opened in some of its congeners yielding the side chain with terminal free carboxylic acid and methyl moieties, (2) stelliferins oxygenated at C-22, and 3) globostellatic acids whose main feature is a carboxyl group at C-4. In addition to triterpenoids, the isomalabaricane core has been also recognized in some sesqui- and/or sesterterpenes. The isomalabaricane terpenoids were sometimes trivially named according to their sponge origin.

Upon light exposure, the isomalabaricane-type terpenes readily isomerize at the C-13 position. Therefore, during isolation and characterization processes, they rapidly equilibrate into a 1:1 mixture of the 13E and 13Z isomers [78–80,88,89,98,99]. Nevertheless, these compounds continue to gain a great deal of attention because of their significant cytotoxic activity [79,89], whereas the nature of the natural isomer, either 13E or 13Z or both, is still unresolved. Recently it was reported that the ¹H NMR spectrum of a crude extract obtained from the fresh sponge Rhabdastrella aff. distinca (Hainan, the South China Sea) revealed that it mostly contained isomalabaricanes with the 13E-configuration (H-15 of most derivatives appeared around 7.0 ppm). Thus, the 13Z isomers were suggested in this case to be formed through isomerization during the isolation and analytical procedures [86].

Stelletins comprise the first group of isomalabaricane-type triterpenoids. Stelletin A (56) was recognized in 1981 as a yellow triterpenoidal pigment from the Fijian marine sponge Jaspis stellifera [73]. Later, it was obtained together with its E isomer, stelletin B (57), from the marine sponge Stelletta tenuis collected off Hainan Island, China [77]. Stelletin A (56) revealed significant cytotoxicity against murine leukemia P388 cell line with IC₅₀ of 2.1 nM [77].

Stelletin G (62), with an opened γ-pyrone and featuring terminal -COOH and -CH₃ functionalities, was isolated together with 56 from J. stellifera [73]. Later, stelletins G (62) was reported from the Australian marine sponge Stelletta sp. together with stelletins E (60) and F (61) [78]. The E isomer of stelletin G (62) was isolated from the marine sponge Rhabdastrella globostellata collected from the South China Sea and it was given the trivial name rhabdastrellic acid–A (63) [75,76].

Research interests have been intensively driven toward this group of triterpenoidal derivatives, which led to the isolation of eight further stelletins C,D, and H–M [78–80,82,85], in addition to 22,23-dihydrostelletin D [81].

Rhabdastrellins A–F (64–69), along with stelletins L (70) and M (71), were obtained from the marine sponge Rhabdastrella aff. distinca collected from a coral reef off Hainan, in the South China Sea [86]. Four of the rhabdastrellins (64–67) exhibited a primary alcohol moiety at C-29 instead of a methyl group as for the stelletins and the other two rhabdastrellins E (68) and F (69). While all rhabdastrellins and stelletins L and M share a hydroxyl group at C-3 instead of a carbonyl group as in other stelletins [86].

The antiproliferative profile of stelletins A–F (56–61) has been examined at the National Cancer Institute (NCI, Australia) against 60 cell lines. Due to the rapid isomerization upon light exposure, stelletins were tested as isomeric pairs. Stelletin C(58)/D(59) pair was the most potent derivative with a mean panel GI₅₀ of 0.09 μM. The stelletin E(60)/F(61) pair was approximately 10-times less potent (mean GI₅₀ of 0.98 μM) [79].

Apoptotic cell death is a stress response of cells to cytotoxic agents that might be executed either through a receptor-mediated pathway that activates caspase-8 or through a receptor-independent pathway that involves the cyclin-kinase inhibitors p53/p21. Both pathways lead to a translocation of pro-apoptotic Bax protein to the mitochondria, thereby resulting in a dissipation of mitochondrial membrane potential, activation of caspase-3, and execution of the apoptotic machinery [84].

Stelletin A (56) demonstrated a differential cytotoxicity against human leukemia HL-60 cells (IC₅₀ 0.9 μM) compared to human prostate cancer LNCaP cells (IC₅₀ 260 μM) by activation of NADPH oxidase, which induces oxidative cell death through a FasL–caspase-3-apoptotic pathway [83]. Stelletins B (57) and E (60) revealed selective cytotoxicity toward p21-deficient human colon tumor HCT-116 cells with IC₅₀ values of 0.043 and 0.039 μM, respectively [80]. Stelletins L (70) and M (71) exhibited selective cytotoxicity against stomach cancer AGS cells with IC₅₀ values of 3.9 and 2.1 μM, respectively [85]. Rhabdastrellic acid–A (63) also inhibited proliferation of human leukemia HL-60 cells with an IC₅₀ value of 1.5 μM through inhibition of the PI3K/Akt pathway and induction of caspase-3 dependent-apoptosis [76]. Only rhabdastrellin A (64) possessed moderate inhibitory activity toward human leukemia HL-60 cells (IC₅₀ = 8.7 μM) while other rhabdastrellins were inactive (IC₅₀ > 20 μM) [86].

Stelliferins are the second group of isomalabaricane triterpenes. To the best of our knowledge, 13 compounds belonging to this group have been reported. In addition to stelliferins A–F (72–77), which have been isolated from the Okinawan marine sponge Jaspis stellifera [87], stelliferin G (78) and 29-hydroxy derivatives of stelliferins A (79) and E (80) have been isolated from an unidentified species of the genus Jaspis collected near Tonga [89].

The 29-hydroxy derivative of stelliferin D (81) together with 3-epimeric isomers of 79 and 80 were reported from the marine sponge Stelletta globostellata collected by SCUBA off Mage-jima Island, Japan [88]. Whereas stelliferin riboside (72a), the first example of a glycosylated stelliferin, was isolated from the Fijian sponge Geodia globostellata [90].

Stelliferins A–F (72–77) exhibited potent in vitro antineoplastic activities against murine lymphoma L1210 cells (IC₅₀ of 1.1–5.0 μM) and human epidermoid carcinoma KB cells (IC₅₀ of 2.8–13.0 μM) [87], while the isomeric mixture of stelliferin G (78) and 29-hydroxystelliferin A (79) showed the highest inhibitory activity against the melanoma MALME-3M cell line with IC₅₀ values of 0.2 and 0.4 μM, respectively [89]. Stelliferin riboside (72a) displayed moderate cytotoxicity against ovarian A2780 cancer cells (IC₅₀ = 60 μM) [90].

Due to the significant antiproliferative activity exhibited by stelletins and stelliferins, research efforts have been directed towards their chemical synthesis. In 1999, Raeppel et al. successfully synthesized the common trans-syn-trans perhydrobenz[e]indene moiety in the isomalabaricane-type terpenoids, which enabled the chemical synthesis of stelletins and stelliferins [91].

Globostellatic acid (82) is the prototype of the third group of isomalabaricane-type triterpenoids sharing carboxylation at C-4. It was first isolated together with three other derivatives, globostellatic acids B–D, from the marine sponge Stelletta globostellata collected off Mage Island near Kagoshima, Japan [92].

Other globostellatic acid congeners, F–M, and X methyl esters, have been reported from different collections of the Indonesian marine sponge Rhabdastrella globostellata [93,94].

Globostellatic acids revealed potent cytotoxicity similar to the stelletins and stelliferins. Globostellatic acids A–D demonstrated significant cytotoxicity against murine leukemia P388 cells with IC₅₀ values of 0.2–0.8 μM [92].

For cytotoxicity toward mouse lymphoma L5178Y cells, the 3-O-deacetyl congeners, globostellatic acids H/I (83/84) were the most active with an IC₅₀ of 0.31 nM. However, acetylation of the C-3 hydroxyl group decreases its bioactivity abruptly, as in globostellatic acids J/K (85/86), with an IC₅₀ of 8.28 nM. The reverse was found for the 13Z isomer of stelliferin riboside (72a) that revealed higher activity than its 3-O-deacetyl congener with IC₅₀ values of 0.22 and 2.40 nM, respectively [93].

On the other hand, globostellatic acids showed only moderate or no cytotoxicity against either human cervix carcinoma HeLa or rat pheochromocytoma PC-12 cell lines [93]. Two globostellatic acid X methyl esters (87 and 88), possessing the 13E-geometry, inhibited proliferation of human umbilical vein endothelial cells (HUVECs), 80- to 250-fold greater in comparison to several other cell lines and hence inhibiting angiogenesis which if pathologically uncontrolled, accompanies several diseases such as atherosclerosis, arthritis, diabetic retinopathy, and cancer.

13E,17E- Globostellatic acid X methyl ester (87) also inhibited basic fibroblast growth factor (bFGF)-induced tubular formation and vascular endothelial growth factor (VEGF)-induced migration of HUVECs. In addition, 87 induced apoptosis of HUVECs without affecting their VEGF-induced phosphorylation of ERK1/2 kinases [94].

Geoditins, which are stelliferin-related isomalabaricane triterpenoids, are mainly oxygenated at both C-22 and C-25. Five geoditins (89–93) were obtained from the marine sponges Geodia japonica [95] and Rhabdastrella aff. distinca [96] collected at different locations in the South China Sea.

Geoditins (89–93) were submitted for bioassays against several human tumor cell lines including HL-60 (promyelocytic leukemia), PC-3MIE8 (prostate carcinoma), BGC-823 (gastric carcinoma), MDA-MB-423 (breast carcinoma), Bel-7402 (hepatocellular carcinoma) and HeLa (cervical carcinoma) cells. Isogeoditin A (91) showed significant cytotoxicity towards the former three cell lines with IC₅₀ values of 0.3, 0.2 and 1.0 μM, respectively. While 13E-isogeoditin A (92) revealed no cytotoxic activity, implying that the Z-geometry at C-13 enhances antiproliferative activity compared to the E-form [96]. Geoditin A (89) proved to be cytotoxic against HL-60 cells [IC₅₀ = 6.7 μM)] while geoditin B (90) exhibited relatively weak cytotoxicity. Mechanistically, geoditin A (89) markedly induced reactive oxygen species (ROS), decreased mitochondrial membrane potential and mediated a caspase-3 apoptosis pathway [97].

Jaspiferals (94–103) and aurorals (104–107) are isomalabaricane-type terpenoids differentiated into nortriterpenoids, norsesterterpenoids and norditerpenes possessing a 3α-hydroxy group. Jaspiferals A–G (94–100) were purified from the Okinawan marine sponge Jaspis stellifera [98] while the 3-O-acetyl and methyl ester derivatives of jaspiferals B (101), D (102) and E (103) were obtained from a new species of Jaspis collected at the Vanuatu Islands [99]. Aurorals (104–107) have been isolated from the New Caledonian marine sponge Rhabdastrella globostellata [100].

Jaspiferals A–G (94–100) exhibited in vitro cytotoxicity against murine lymphoma L1210 cells with IC₅₀ values of 1.6–10.4 μM, whereas only jaspiferals E–G (98–100) revealed antineoplastic activity against human epidermoid carcinoma KB cells (IC₅₀ of 5.2–14.7 μM) [98]. Jaspiferal G (100) exhibited antifungal activity against Cryptococcus neoformans (MIC, 144 μM) and Trichophyton memtagrophytes (MIC, 36 μM), and antibacterial activity against Sarcina lutea (MIC, 144 μM), while the mixture of jaspiferals E (98) and F (99) showed antifungal activity against T. memtagrophyes (MIC, 134 μM) [98]. On the other hand, the 3-O-acetyl, methyl ester derivatives of jaspiferals B (101), D (102) and E (103) revealed weak cytotoxicity against L1220 cells (IC₅₀ > 8.8 μM) [99].

Aurorals (104–107), which differ from jaspiferals C–F (96–99) by the presence of a primary alcohol group at the C-4 position, exhibited stronger cytotoxicity against KB cells. The isomeric mixtures of aurorals (104/105), (106/107) and jaspiferals C/D (96/97) showed IC₅₀ values of 0.5, 22.2 and 13.3 μM, respectively, while jaspiferals E/F (98/99) were inactive up to 27 μM [100].

Jaspolides represent another example of isomalabaricane-type terpenoids of either monomeric or dimeric congeners. Monomeric congeners of jaspolides could be classified into triterpenes, jaspolides A (108) and B (109); sesterterpene, jaspolide F (113); diterpenes, jaspolides C (110) and D (111); and nortriterpene, jaspolide E (112) which were all isolated from the marine sponge Jaspis sp. collected from the South China Sea [101].

A presumable biogenetic transformation scheme of jaspolides A–F (108–113) (Figure 2), revealed that light-induced isomerization is responsible for the jaspolides A/B (108/109) and C/D (110/111) isomeric pairs. In addition it substantiated jaspolide D (111) as a precursor to jaspolide F (113), formed through condensation with an isoprenyl pyrophosphate (IPP) followed by oxidation at a terminal methyl group [101]. Jaspolides G (114) and H (115) are dimeric isomalabaricane congeners which were isolated from the same Chinese sponge Jaspis sp. and their proposed biogenetic pathway (Figure 3) suggested that they were derived from stelletin A (56) yielding the left moiety, and the nortriterpene, geoditin A (89) yielding the right moiety [102].

Jaspolide B (109) arrested HL-60 cells in the G₂/M phase of the cell cycle and induced apoptosis in a dose- and time-dependent manner. Jaspolide B with an IC₅₀ value of 0.61 μM exhibited a comparable efficacy as that of paclitaxel (IC₅₀ = 0.78 μM). These results suggested 109 to be a promising anticancer agent for chemotherapy of leukemia by prohibiting cell cycle progression at the G₂/M phase and triggering apoptosis [103].

In a further study with human hepatoma cells, jaspolide B (109) inhibited the growth of Bel-7402 and HepG2 cells with IC₅₀ values of 29.1 and 29.5 μM, respectively. Incubation with 0.5 μM of 109 caused time-dependent induction of apoptosis in Bel-7402 as confirmed by the enhancement of mitochondrial masses, cell membrane permeability, and nuclear condensation. In conclusion, the anticancer effect of jaspolide B involves multiple mechanisms including apoptosis induction, cell cycle arrest, and microtubule disassembly but these were weaker than colchicine, a well-known microtubule disassembly agent [104]. These multiple mechanisms of jaspolide B, especially the apoptosis induction, pose interesting perspectives for further exploration of the isomalabaricane-type terpenes as potential anticancer agents.

Since the class of isomalabaricane terpenoidal metabolites has been reported in the literature from different sponge species of the genera Rhabdastrella, Stelletta, Jaspis, and Geodia as shown above, the identity of these sponges has been questioned and reevaluated. Interestingly, the taxonomic reevaluation of these sponges revealed that they all might be reassigned to Rhabdastrella globostellata (class Demospongiae; order Astrophorida; family Ancorinidae) [80]. However, it could not be ascertained for the isomalabaricane producing Stelletta sp. from Somalia [74] and Stelletta tenuis from China [77]. The latter, collected from an identical location (Hainan Island), was taxonomically recognized as R. globostellata [75].

3.2. Steroidal saponins

In the Kingdom Animalia, steroidal and triterpene glycosides are predominant metabolites of starfishes and sea cucumbers, respectively [108]. In addition, these types of glycosides have also been isolated from marine sponges. To the best of our knowledge, around 80 sponge triterpenoidal glycosides have been reported to date, including erylosides [107–114], formosides [115,116], nobiloside [117], and sokodosides [118] from different sponge species of the genus Erylus; sarasinosides from the marine sponges Asteropus sarasinosum [120–123], Melophlus isis [124], and M. sarassinorum [125]; mycalosides from Mycale laxissima [126–128]; ectyoplasides and feroxosides from the Caribbean marine sponge Ectyoplasia ferox [129,130]; ulososides from Ulosa sp. [131,132]; wondosterols from a two-sponge association [133]; and pachastrelloside A from a marine sponge of the genus Pachastrella [134]. The majority of these glycosides belong to norlanostane-triterpenoidal saponins, derived from lanosterol or related triterpenes as a result of oxidative elimination of one or two methyl groups.

Penasterol (116), an acidic steroidal metabolite closely related to lanosterol (117) and possessing potent antileukemic activity, was originally isolated from the Okinawan marine sponge Penares sp. in 1988 [105]. Penasterol together with its analogs penasterone and acetylpenasterol, isolated from the Okinawan marine sponge Penares incrustans, inhibit IgE-dependent histamine release from rat mast cells [106].

Eryloside A (118) was the first eryloside congener isolated from the Red Sea sponge Erylus lendenfeldi (class Demospongiae; order Choristida; family Geodiidae) [107]. Twenty eight additional erylosides (A–F, F₁–F₇, G–V) have been reported from different species of the genus Erylus including E. goffrilleri [109,114], E. formosus [110,113], E. nobilis [111], in addition to another collection of E. lendenfeldi [112].

For eryloside A (118), antitumor activity against murine leukemia P388 cells with an IC₅₀ = 5.7 μM and antifungal activity against Candida albicans (MIC = 21.1 μM) have been reported [107]. Eryloside E (119), glycosylated at C-30 through an ester linkage with the rare t-butyl substitution of the side chain, was isolated from an Atlantic sponge Erylus goffrilleri [109]. It revealed immunosuppressive activity with an EC₅₀ of 1.8 μM and a therapeutic index (TI) of 9.5, which indicated that the immunosuppressive effect is specific and is not due to a general cytotoxic effect [109].

Eryloside F (120) was reported from two collections of the marine sponge E. formosus [110] and exhibited potent thrombin receptor antagonistic activity. Furthermore, it inhibited platelet aggregation in vitro. Against hepytocyte HepG2 cells, 120 possessed little activity [110]. Erylosides F₁ (121) and F₃ (122) were isolated along with nine other congeners from the Caribbean sponge E. formosus [113]. In contrast to its 24-epimer, eryloside F₃ (122) induced early apoptosis in Ehrlich carcinoma cells at 130 μM, while erylosides F (120) and F₁ (121) activated the Ca²⁺ influx into mouse spleenocytes at the same doses [113].

Erylosides K (123) and L (124) have been obtained together with 118 from another collection of the Red Sea marine sponge Erylus lendenfeldi [112]. While 123 was identified as the 24,25-didehydro congener of eryloside A, eryloside L (124) incorporated a naturally unprecedented 8α,9α-epoxy-4α-methyl-8,9-secocholesta-7,9(11),14-triene skeleton [112]. Erylosides A (118) and K (123) led to a 50% mortality rate in the brine shrimp assay at a concentration of 0.14 mM. Whereas, eryloside L (124) was inactive at the same concentration [112].

In addition to erylosides, the marine sponges E. formosus and E. nobilis produced other steroidal saponins identified as formosides A (125) [115] and B (126) [116]; and nobiloside (127) [117], respectively, whilst sokodosides A (128) and B (129) have been obtained from the marine sponge Erylus placenta [118]. A convergent synthesis of the trisaccharides of 129 has been successfully performed [119].

Formoside A (125) was first reported by Jaspars and Crews in 1994 from the Caribbean marine sponge Erylus formosus [115]. Later, it was isolated together with formoside B (126) from another collection of the same sponge from the Bahamas [116]. Formoside A (125) and its N-acetyl galactosamine derivative, formoside B (126) possess deterrent properties against predatory fish. Therefore, they were suggested to have important ecological functions, resembling those ascribed to similar compounds present in sea stars, sea cucumbers, and terrestrial plants [116].

Nobiloside (127), a penasterol saponin, was reported from the marine sponge E. nobilis collected off Shikine-jima Island, Japan [117] and revealed the presence of a carboxylic group at C-30 in addition to uronic acid moieties. Nobiloside (127) inhibited neuraminidase from the bacterium Clostridium perfrigens with an IC₅₀ of 0.5 μM [117].

Sokodosides A (128) and B (129) were obtained from the marine sponge E. placenta collected off Hachijo Island, Japan [118]. They possessed a novel carbon skeleton as characterized by the presence of a combination of an isopropyl side chain and the 4,4-dimethyl steroid nucleus. Moreover, sokodoside B (129) exhibited double bonds at unusual positions Δ^{8(9),14(15),16(17)}.

Both sokodosides displayed moderate antifungal activity against the fungus Mortierella ramanniana and the yeast Saccharomyces cereivisiae, but no antibacterial activity was found. Additionally, sokodosides A (128) and B (129) exhibited cytotoxic activity against P388 cells with IC₅₀ values of 103 and 62 μM, respectively [118].

Sarasinosides follow erylosides in the number of isolated metabolites. To date, 21 sarasinoside congeners have been reported, which all featured a carbonyl group at C-23 position. Sarasinoside A₁ (130) was the first steroidal saponin reported in the literature, even before eryloside A (118), from the Palauan marine sponge Asteropus sarasinsum, together with other eight new congeners [120–122]. Then, from the same sponge collected in the Solomon Islands, four additional sarasinosides D–G were reported [123]. From each of the marine sponges Melophlus isis (Guam) [124] and M. sarassinorum (Indonesia) [125], four sarasinoside congeners were isolated.

Among the sarasinoside congeners known to date, sarasinoside A₁ (130) and B₁ (131) exhibited piscicidal activity against Poecilia reticulata with LD₅₀ values (48 h) of 0.3 and 0.6 μM, respectively [120,122].

Sarasinoside A₁ is known to possess moderate cytotoxicity in vitro against leukemia P388 [121] and K562 [124] cell lines with IC₅₀ values of 2.2 and 5.0 μM, respectively. Sarasinoside A₃, which differs from A₁ (130) in having Δ^8(9),14(15) instead of Δ⁸⁽⁹⁾ unsaturation, exhibited mild cytotoxic activity with an IC₅₀ of 13.3 μM [124].

In the agar diffusion antimicrobial assay (10 μg/disc), sarasinoside A₁ showed strong and selective activity against the yeast S. cerevisiae but was inactive against B. subtilis and E. coli. On the other hand, sarasinoside J (132) was active against S. cerevisiae and showed moderate antibacterial activity against B. subtilis and E. coli [125].

Mycalosides include eleven steroidal saponin congeners that were isolated from the Caribbean marine sponge Mycale laxissima (class Demospongiae; order Poecilosclerida; family Mycalidae) collected near San-Felipe Island, Cuba [126–128]. They were all characterized by having oxygenated C-4, C-15, and C-21 positions.

Mycaloside A (133) and G (134) as well as the total glycoside fraction did not influence nonfertilized eggs and the developing embryo up to the 8-blastomere stage at concentrations of up to 94.6 μM. However, these compounds were effective as spermatostatics when preincubated for 15 min with sea urchin sperm with an EC₅₀ of 3.04 μM. The total glycoside fraction generated a less toxic effect (EC₅₀ = 7.03 μg/mL) [127].

Ectyoplasides A (135) and B (136) were first isolated from the Caribbean sponge E. ferox (class Demospongiae; order Axinellida; family Raspaliidae) collected along the coasts of San Salvador Island, Bahamas [129]. The compounds are C-4 norpenasterol triterpenoidal derivatives. Later, ectyoplasides were reisolated together with feroxosides A (137) and B (138) from the same sponge collected along the coasts of Grand Bahama Island [130]. Feroxosides have been shown to be unusual C-4 norlanostane triterpenes glycosylated with a rhamnose-containing tetrasaccharide chain.

Against murine fibrosarcoma WEHI164, murine leukemia P388, and murine monocyte-macrophage J774 cell lines, both ectyoplasides (135 and 136) exhibited moderate in vitro cytotoxic activity with IC₅₀ values ranging from 9.0 to 11.4 μM [129], whilst against the latter cell line, feroxosides (137 and 138) were mildly cytotoxic (IC₅₀ = 17.6 μM) [130].

Pachastrelloside A (139) was obtained from the marine sponge Pachastrella sp. (Kagami Bay, Japan) and revealed the presence of a cholest-5,24-diene-2α,3β,4β,7α-tetraol aglycone that was glycosylated at the C-4 and C-7 positions with β-D-xylopyranose and β-D-galactopyranose moieties, respectively [134].

A Korean sponge-association composed of Poecillastra wondoensis and Jaspis wondoensis resulted in the isolation of wondosterols A–C (140–142), which are structurally related to 139 [133]. Wondosterols were shown to have a β-OH group at C-7 and they were all diglycosylated at C-3 with β-D-xylopyranose connected to β-D-galactopyranose.

Wondosterols A–C (140–142) were weakly cytotoxic against P388 cells (IC₅₀ = 63 μM) and at a concentration of 10 μg/disk only 140 and 142 showed antibacterial activities against P. aeruginosa and E. coli [133]. Pachastrelloside A (139) inhibited cell division of fertilized starfish (Asterina pectinifera) eggs at 35 μM [134].

4. Future Aspects

The enormous diversity of marine natural products combined with improved global concerns to find new therapeutic agents for the treatment of different ailments provide the stimulus to evaluate marine natural products in clinical trials. Marine drug discovery faces many obstacles including a sufficient supply, and the low concentrations of some compounds that may account for less than 10⁻⁶% of the wet weight [135]. However, there have been substantial advances, suggesting that sustainable sourcing could be achievable. Since the continuous and exhaustive harvesting of terrestrial drug lead resources proved to be unreliable and resulted in the frequent re-isolation of known compounds, researchers from academia and from pharmaceutical companies alike are now turning their focus to the sea in search for new lead structures from nature. Nevertheless, the large scale production of marine natural products for clinical use is a real challenge, and therefore environmentally sound and economically feasible alternatives are required.

Chemical synthesis is among the first strategies to be explored, but unfortunately the structural complexity of marine metabolites with novel mechanisms of action and high selectivity has resulted in only a few successful examples with this strategy such as the conus toxin ziconotide [136]. A second strategy, but also as labor-intensive, is to study the pharmacological significance of marine natural product pharmacophores and then attempt to define the critical pharmacophore that can result in practical drugs based on a marine prototype via chemical synthesis, degradation, modification or a combination of these.

Aquaculture of the source organisms, including sponges, tunicates, and bryozoans, with an aim at securing a sustainable supply of the active constituent(s), has progressed notably in cancer applications. However, in most cases the biomass currently generated is still far from that required, should a marine-based drug finally enter the pharmaceutical market [137]. Furthermore, the cultivation of invertebrates in their natural environment is subject to several hazards and threats, such as destruction by storms or diseases. An intriguing strategy has been to identify the true producers of bioactive compounds and to explore whether or not they are of microbial origin including bacteria, cyanobacteria, or fungi that are known to harbour within the tissues of marine invertebrates.

If bacterial or other associated microorganisms proved to produce the compounds of interest, a careful design of special culture media would be crucial for large-scale fermentation e.g., ET-743 production. Currently, only 5% or less of the symbiotic bacteria present in marine specimens can be cultivated under standard conditions [138]. Consequently, molecular approaches offer particularly promising alternatives through the transfer of biosynthetic gene clusters to a vector suitable for large-scale fermentation, thereby avoiding the obstacles in culturing symbiotic bacteria.

Oceans will play a potential role in the future to control and relieve the global disease burden. In spite of the substantial development that has been achieved in disclosing novel drug leads from marine resources, more efforts are still required for more chemical entities to reach to clinical applications.

Acknowledgements

Preparation of this review was supported by a grant of BMBF (to P.P.). A scholarship granted and financed by the Egyptian government (predoctoral fellowship for S.S.E.) is gratefully acknowledged.

Samples Availability: Available from the authors.

References and Notes 1

Braekman

Daloze

Chemical defence in sponges

Pure Appl Chem198658357364

10.1351/pac198658030357

Ruzicka

The isoprene rule and the biogenesis of terpenic compounds

Experientia19539357367

10.1007/BF02167631

13116962

Bergmann

Johnson

The chemistry of marine animals. I. The sponge Microciona pralifera

Z Physiol Chem1933222220226

10.1515/bchm2.1933.222.5-6.220

Fusetani

Biofouling and antifouling

Nat Prod Rep20042194104

10.1039/b302231p

15039837

De Silva

Scheuer

Manoalide, an antibiotic sesterterpenoid from the marine sponge Luffariella variabilis (Polejaeff)

Tetrahedron Lett19802116111614

10.1016/S0040-4039(00)77766-5

De Silva

Scheuer

Three new sesterterpenoid antibiotics from the marine sponge Luffariella variabilis (Polejaeff)

Tetrahedron Lett19812231473150

10.1016/S0040-4039(01)81849-9

Kernan

Faulkner

Jacobs

The luffariellins, novel anti-inflammatory sesterterpenes of chemotaxonomic importance from the marine sponge Luffariella variabilis

J Org Chem19875230813083

10.1021/jo00390a021

Albizati

Holman

Faulkner

Glaser

Jacobs

Luffariellolide, an anti-inflammatory sesterterpene from the marine sponge Luffariella sp

Experientia198743949950

10.1007/BF01951682

Kernan

Faulkner

Parkanyi

Clardy

de Carvalho

Jacobs

Luffolide, a novel anti-inflammatory terpene from the sponge Luffariella sp

Experientia198945388390

10.1007/BF01957489

2707379

König

Wright

Sticher

Four new antibacterial sesterterpenes from a marine sponge of the genus Luffariella

J Nat Prod199255174178

10.1021/np50080a004

1624940

Potts

BCM

Capon

Faulkner

Luffalactone and (4E,6E)-dehydromanoalide from the sponge Luffariella variabilis

J Org Chem19925729652967

10.1021/jo00036a043

Butler

Capon

The luffarins (A–Z), novel terpenes from an Australian marine sponge Luffariella geometrica

Aust J Chem19924517051743

10.1071/CH9921705

Tsuda

Shigemori

Ishibashi

Sasaki

Kobayashi

Luffariolides A–E, new cytotoxic sesterterpenes from the Okinawan marine sponge Luffariella sp

J Org Chem19925735033507

10.1021/jo00038a051

Kobayashi

Zeng

Ishibashi

Sasaki

Luffariolides F and G, new manoalide derivatives from the Okinawan marine sponge Luffariella sp

J Nat Prod199356436439

10.1021/np50093a020

8482949

Reddy

MVR

Harper

Faulkner

Luffasterols A–C, 9,11-secosterols from the Palauan sponge Luffariella sp

J Nat Prod1997604143

10.1021/np9606207

9014351

Tsuda

Endo

Mikami

Fromont

Kobayashi

Luffariolides H and J, new sesterterpenes from a marine sponge Luffariella

J Nat Prod20026515071508

10.1021/np0202071

12398555

Namikoshi

Suzuki

Meguro

Nagai

Koike

Kitazawa

Kobayashi

Oda

Yamada

Manoalide derivatives from a marine sponge Luffariella sp. collected in Palau

Fish Sci200470152158 18

Ettinger-Epstein

Motti

de Nys

Wright

Battershill

Tapiolas

Acetylated sesterterpenes from the Great Barrier reef sponge Luffariella variabilis

J Nat Prod200770648651

10.1021/np060240d

17295541

Gauvin-Bialecki

Aknin

Smadja

24-O-Ethylmanoalide, a manoalide-related sesterterpene from the marine sponge Luffariella cf. variabilis

Molecules20081331843191

10.3390/molecules13123184

19078858

Kobayashi

Okamoto

Hayashi

Yokoyama

Sasaki

Kitagawa

Marine natural products. XXXII. Absolute configurations of C-4 of the manoalide family, biologically active sesterterpenes from the marine sponge Hyrtios erecta

Chem Pharm Bull199442265270

10.1248/cpb.42.265

8149454

Bourguet-Kondracki

Debitus

Guyot

Biologically active sesterterpenes from a new Caledonian marine sponge Hyrtios sp

J Chem Res1996192193 22

Cambie

Craw

Bergquist

Karuso

Chemistry of sponges, III. Manoalide monoacetate and thorectolide monoacetate, two new seterterpenoids from Thorectandra excavatus

J Nat Prod198851331334

10.1021/np50056a026

De Rosa

de Stefano

Zavodnik

Cacospongionolide: a new antitumoral sesterterpene, from the marine sponge Cacospongia mollior

J Org Chem19885350205023

10.1021/jo00256a022

Tasdemir

Concepción

Mangalindan

Harper

Hajdu

Ireland

New terpenoids from a Cacospongia sp. from the Philippines

Tetrahedron20005690259030

10.1016/S0040-4020(00)00755-9

Montagnac

Païs

Debitus

Fasciospongides A, B and C, new manoalide derivatives from the sponge Fasciospongia sp

J Nat Prod199457186190

10.1021/np50103a032

De Rosa

Crispino

de Giulio

Iodice

Pronzato

Zavodnik

Cacospongionolide B, a new sesterterpene from the sponge Fasciospongia cavernosa

J Nat Prod19955817761780

10.1021/np50125a024

8594155

De Rosa

Crispino

de Giulio

Iodice

Tommonaro

Cavernosolide, a new sesterterpene from a Tyrrhenian sponge

J Nat Prod199760844846

10.1021/np970183b

De Rosa

Carbonelli

Two new luffarin derivatives from the Adriatic Sea sponge Fasciospongia cavernosa

Tetrahedron20066228452849

10.1016/j.tet.2006.01.014

Elkhayat

Edrada

Ebel

Wray

van Soest

Wiryowidagdo

Mohamed

Müller

WEG

Proksch

New luffariellolide derivatives from the Indonesian sponge Acanthodendrilla sp

J Nat Prod20046718091817

10.1021/np040118j

15568767

Ueoka

Nakao

Fujii

van Soest

RWM

Matsunaga

Aplysinoplides A–C, cytotoxic sesterterpnes from the marine sponge Aplysinopsis digitata

J Nat Prod20087110891091

10.1021/np8001207

18461996

De Freitas

Blankemeier

Jacobs

In vitro inactivation of the neurotoxic action of β-bungarotoxin by the marine natural product, manoalide

Experientia198440864865

10.1007/BF01951998

6468604

Lombardo

Dennis

Cobra venom phospholipase A₂ inhibition by manoalide. A novel type of phospholipase inhibitor

J Biol Chem198526072347240

3997864

Glaser

Jacobs

Molecular pharmacology of manoalide. Inactivation of bee venom phospholipase A₂

Biochem Pharmacol198635449453

10.1016/0006-2952(86)90218-2

3947381

Glaser

Jacobs

Inactivation of bee venom phospholipase A₂ by manoalide. A model based on the reactivity of manoalide with amino acids and peptide sequences

Biochem Pharmacol19873620792086

10.1016/0006-2952(87)90134-1

3111475

Bennett

Mong

Clarke

Kruse

Crooke

Differential effects of manoalide on secreted and intracellular phospholipases

Biochem Pharmacol198736733740

10.1016/0006-2952(87)90727-1

3103628

Glaser

de Carvalho

Jacobs

Kernan

Faulkner

Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A₂ inactivation

Mol Pharmacol198936782788

2586492

Jacobson

Marshall

Sung

Jacobs

Inactivation of human synovial fluid phospholipase A₂ by the marine natural product, manoalide

Biochem Pharmacol19903915571564

10.1016/0006-2952(90)90521-L

2337412

Ortiz

Pisabarro

Gago

Molecular model of the interaction of bee venom phospholipase A₂ with manoalide

J Med Chem19933618661879

10.1021/jm00065a010

8515424

Deems

Lombardo

Morgan

Mihelich

Dennis

The inhibition of phospholipase A₂ by manoalide and manoalide analogues

Biochim Biophys Acta1987917258268

10.1016/0005-2760(87)90130-5

3801502

Reynolds

Morgan

Hite

Mihelich

Dennis

Phospholipase A₂ inhibition and modification by manoalogue

J Am Chem Soc198811051725177

10.1021/ja00223a044

Potts

BCM

Faulkner

Jacobs

Phospholipase A₂ inhibitors from marine organisms

J Nat Prod19925517011717

10.1021/np50090a001

1294693

Reynolds

Mihelich

Dennis

Inhibition of venom phospholipase A₂ by manoalide and manoalogue

J Biol Chem19912661651216517

1885583

Potts

BCM

Faulkner

de Carvalho

Jacobs

Chemical mechanism of inactivation of bee venom phospholipase A₂ by the marine natural products manoalide, luffariellolide, and scalaradial

J Am Chem Soc199211450935100

10.1021/ja00039a021

De Rosa

Giordano

Scettri

Sodano

Soriente

Pastor

Alcaraz

Payá

Synthesis and comparison of the anti-inflammatory activity of manoalide and cacospongionolide B analogues

J Med Chem19984132323238

10.1021/jm980027h

9703468

Mann

Sponges to wipe away pain

Nature1992358540

10.1038/358540a0

1501709

Blanchard

Epstein

Boisclair

Rudolph

Pal

Dysidiolide and related γ-hydroxybutenolide compounds as inhibitors of the protein tyrosine phosphatase, CDC25

Bioorg Med Chem Lett1999925372538

10.1016/S0960-894X(99)00431-X

10498203

Charan

McKee

Boyd

Thorectandrols A and B, new cytotoxic sesterterpenes from the marine sponge Thorectandra species

J Nat Prod200164661663

10.1021/np000544e

11374971

Charan

McKee

Boyd

Thorectandols C, D, and E, new sesterterpenes from the marine sponge Thorectandra sp

J Nat Prod200265492495

10.1021/np010439k

11975486

De Rosa

de Giulio

Crispino

Iodice

Tommonaro

Further bioactive sesterterpenes from the Tyrrhenian sponge Fasciospongia cavernosa

Nat Prod Res199710267274 50

Barrero

Alvarez-Manzaneda

Chahboun

Cuerva

Segovia

Synthetic applications of the thermal rearrangement of ozonides: first enantiospecific synthesis of marine metabolite Luffarin W

Synlett2000912691272 51

Boukouvalas

Robichaud

Maltais

A unified strategy for the regiospecific assembly of homoallayl-substituted butenolides and γ-hydroxybutenolides: first synthesis of luffariellolide

Synlett20061624802482 52

Gross

König

Terpenoids from marine organisms: unique structures and their pharmacological potential

Phytochem Rev20065115141

10.1007/s11101-005-5464-3

Kernan

Barrabee

Faulkner

Variation of the metabolites of Chromodoris funerea: comparison of specimen from a Palauan marine lake with those from adjacent waters

Comp Biochem Physiol198889B275278 54

Sullivan

Faulkner

An antimicrobial sesterterpene from a Palauan sponge

Tetrahedron Lett198223907910

10.1016/S0040-4039(00)86979-8

Schmidt

Faulkner

Palauolol, a new anti-inflammatory sesterterpene from the sponge Fascaplysinopsis sp. from Palau

Tetrahedron Lett19963739513954

10.1016/0040-4039(96)00718-6

De Rosa

Puliti

Crispino

de Giulio

de Sena

Iodice

Mattia

25-Deoxycacospongionolide B and cacospongionolide C, two new terpenoids from the sponge Fasciospongia cavernosa

Tetrahedron1995511073110736

10.1016/0040-4020(95)00638-O

Lal

Cambie

Rickard

CEF

Bergquist

Sesterterpene lactones from a sponge species of the genus Dactylospongia

Tetrahedron Lett19943526032606

10.1016/S0040-4039(00)77183-8

Cambie

Lal

Rickard

CEF

A sesterterpene lactone from Petrosaspongia nigra sp. nov

Acta Cryst1996C52709711 59

Gomez-Paloma

Randazzo

Minale

Debitus

Roussakis

New cytotoxic sesterterpenes from the New Caledonian marine sponge Petrosaspongia nigra (Bergquist)

Tetrahedron1997531045110458

10.1016/S0040-4020(97)00656-X

Randazzo

Debitus

Minale

Pastor

Alcaraz

Payá

Gomez-Paloma

Petrosaspongiolodes M–R: new potent and selective phosphoplipase A₂ inhibitors from the New Caledonian marine sponge Petrosaspongia nigra

J Nat Prod199861571575

10.1021/np9704922

9599251

De Marino

Iorizzi

Zollo

Debitus

Menou

J.-L

Ospina

Alcaraz

Payá

New pyridinium alkaloids from a marine sponge of the genus Spongia with a human phospholipase A₂ inhibitor profile

J Nat Prod200063322326

10.1021/np990374+

10757711

Balsinde

Balboa

Insel

Dennis

Regulation and inhibition of phospholipase A₂

Ann Rev Pharmacol Toxicol199939175189

10.1146/annurev.pharmtox.39.1.175

Dal Piaz

Casapullo

Randazzo

Riccio

Pucci

Marino

Gomez-Paloma

Molecular basis of phospholipase A₂ inhibition by petrosaspongiolide M

ChemBioChem20023664671

10.1002/1439-7633(20020703)3:7<664::AID-CBIC664>3.0.CO;2-9

12325001

Monti

Casapullo

Riccio

Gomez-Paloma

Further insights on the structural aspects of PLA₂ inhibition by γ-hydroxybutenolide-containing natural products: a comparative study of petrosaspongiolides M–R

Bioorg Med Chem20041214671474

10.1016/j.bmc.2003.12.038

15018920

Monti

Casapullo

Riccio

Gomez-Paloma

PLA₂-mediated catalytic activation of its inhibitor 25-acetyl-petrosaspongiolide M: serendipitous identification of a new PLA₂ suicide inhibitor

FEBS Lett2004578269274

10.1016/j.febslet.2004.10.100

15589831

Gomez-Paloma

Monti

Terracciano

Casapullo

Riccio

Chemistry and biology of anti-inflammatory marine natural products. Phospholipase A₂ inhibitors

Curr Org Chem2005914191427

10.2174/1385272054880205

Monti

Riccio

Casapullo

Effects of petrosaspongiolide R on the surface topology of bee venom PLA₂: a limited proteolysis and mass spectrometry analysis

Bioorg Chem200937610

10.1016/j.bioorg.2008.09.001

18945473

Monti

Casapullo

Cavasotto

Tosco

Dal Piaz

Ziemys

Margarucci

Riccio

The binding mode of petrosaspongiolide M to the human group IIA phospholipase A₂: exploring the role of covalent and noncovalent interactions in the inhibition process

Chem Eur J20091511551163

10.1002/chem.200801512

19065693

Ferreiro-Mederos

Lanners

Henchiri

Fekih

Hanquet

Hemisynthesis of two marine cheilantane sesterterpenes from (−)-sclareol: first enantioselective synthesis of petrosaspongiolide R

Nat Prod Res200923256263

10.1080/14786410801997075

19235026

Chawla

Dev

A new class of triterpenoids from Ailanthus malabarica DC. Derivatives of malabaricane

Tetrahedron Lett1967848374843

10.1016/S0040-4039(01)89615-5

Sobti

Dev

A direct correlation of (+)-malabaricol with (+)-ambreinolide

Tetrahedron Lett1968922152217

10.1016/S0040-4039(00)89723-3

Paton

Paul

Bajaj

Dev

The structure of malabaricol

Tetrahedron Lett19792041534154

10.1016/S0040-4039(01)86530-8

Ravi

Wells

Croft

Malabaricane triterpenes from a Fijian collection of the sponge Jaspis stellifera

J Org Chem19814619982001

10.1021/jo00323a006

McCabe

Clardy

Minale

Pizza

Zollo

Riccio

A triterpenoid pigment with the isomalabaricane skeleton from the marine sponge Stelletta sp

Tetrahedron Lett19822333073310

10.1016/S0040-4039(00)87601-7

Rao

Deng

Jiang

Rhabdastrellic acid–A, a novel triterpenoid from the marine sponge Rhabdastrella globostellata

J Nat Prod19976011631164

10.1021/np960729e

Guo

J.-F

Zhou

J.-M

Zhang

Deng

Liu

J.-N

Feng

G.-K

Liu

Z.-C

Xiao

D.-J

Deng

S.-Z

Zhu

X.-F

Rhabdastrellic acid–A inhibited PI3K/Akt pathway and induced apoptosis in human leukemia HL–60 cells

Cell Biol Int2008324854

10.1016/j.cellbi.2007.08.009

17920303

Meng

Zeng

Schmitz

Stellettin A, a new triterpenoid pigment from the marine sponge Stelletta tenuis

J Nat Prod19945714501451

10.1021/np50112a017

7807129

McCormick

McKee

Cardellina

IILeid

Boyd

Cytotoxic triterpenes from a marine sponge, Stelletta sp

J Nat Prod19965910471050

10.1021/np960541v

8946745

McKee

Bokesch

McCormick

Rashid

Spielvogel

Gustafson

Alavanja

Cardellina

IIBoyd

Isolation and characterization of new anti-HIV and cytotoxic leads from plants, marine, and microbial organisms

J Nat Prod199760431438

10.1021/np970031g

9170286

Tasdemir

Mangalindan

Concepción

Verbitski

Rabindran

Miranda

Greenstein

Hooper

JNA

Harper

Ireland

Bioactive isomalabaricane triterpenes from the marine sponge Rhabdastrella globostellata

J Nat Prod200265210214

10.1021/np0104020

11858759

Tang

Deng

Pei

Zhang

Lin

A new isomalabaricane triterpenoid from sponge Jaspis sp

Chin Chem Lett200516353355 82

Clement

Hecht

Kingston

DGI

Bioactive isomalabaricane triterpenoids from Rhabdastrella globostellata that stabilize the binding of DNA polymerase β to DNA

J Nat Prod200669373376

10.1021/np0504107

16562838

Liu

Cheung

FWK

Che

C.-T

Stellettin A induces oxidative stress and apoptosis in HL–60 human leukemia and LNCaP prostate cancer cell lines

J Nat Prod200669934937

10.1021/np058122y

16792413

Krysko

Roels

Leybaert

D’Herde

Mitochrondrial transmembrane potential changes support the concept of mitochondrial heterogeneity during apoptosis

J Histochem Cytochem20014912771284

10.1177/002215540104901010

11561012

Lin

H.-W

Wang

Z.-L

J.-H

Shi

Zhang

H.-J

Chen

W.-S

Morris-Natschke

Lin

A.-S

Stellettins L and M, cytotoxic isomalabaricane-type triterpenes, and sterols from the marine sponge Stelletta tenuis

J Nat Prod20077011141117

10.1021/np070069l

17604394

Deng

de Voogd

van Soest

RWM

Proksch

Lin

Rhabdastrellins A – F, isomalabaricane triterpenes from the marine sponge Rhabdastrella aff. distinca

J Nat Prod20087117381741

10.1021/np800324v

18826276

Tsuda

Ishibashi

Agemi

Sasaki

Kobayashi

Stelliferins A–F, new antineoplastic isomalabaricane triterpenes from the Okinawan marine sponge Jaspis stellifera

Tetrahedron19914721812194

10.1016/S0040-4020(01)96129-0

Oku

Matsunaga

Wada

Watabe

Fusetani

New isomalabaricane triterpenes from the marine sponge Stelletta globostellata that induce morphological changes in rat fibroblasts

J Nat Prod200063205209

10.1021/np990333d

10691710

Meragelman

McKee

Boyd

New cytotoxic isomalabaricane triterpenes from the sponge Jaspis species

J Nat Prod200164389392

10.1021/np000478g

11277766

Tabudravu

Jaspars

Stelliferin riboside, a triterpene monosaccharide isolated from the Fijian sponge Geodia globostellifera

J Nat Prod200164813815

10.1021/np010019v

11421753

Raeppel

Weibel

J.-M

Heissler

Synthesis of the trans-syn-trans perhydrobenz[e]indene moiety of the stellettins and the stelliferins

Tetrahedron Lett19994063776381

10.1016/S0040-4039(99)01240-X

Ryu

Matsunaga

Fusetani

Globostellatic acids A–D, new cytotoxic isomalabaricane triterpenes from the marine sponge Stelletta globostelleta

J Nat Prod199659512514

10.1021/np9601317

8778241

Fouad

Edrada

Ebel

Wray

Müller

WEG

Lin

Proksch

Cytotoxic isomalabaricane triterpenes from the marine sponge Rhabdastrella globostellata

J Nat Prod200669211218

10.1021/np050346t

16499318

Aoki

Sanagawa

Watanabe

Setiawan

Arai

Kobayashi

Novel isomalabaricane triterpenes, exhibiting selective anti-proliferative activity against vascular endothelial cells, from marine sponge Rhabdastrella globostellata

Bioorg Med Chem20071548184828

10.1016/j.bmc.2007.04.070

17524651

Zhang

Che

C.-T

Isomalabaricane-type nortriterpenoids and other constituents of the marine sponge Geodia japonica

J Nat Prod20016414891492

10.1021/np0100789

11754596

Deng

van Soest

RWM

Proksch

Lin

Isomalabaricane-type compounds from the marine sponge Rhabdastrella aff. distinca

J Nat Prod20046720332036

10.1021/np040145+

15620246

Liu

JCK

Che

Apoptotic activity of isomalabaricane triterpenes on human promyelocytic leukemia HL-60 cells

Cancer Lett2005230102110

10.1016/j.canlet.2004.12.034

16253766

Kobayashi

Yuasa

Kobayashi

Sasaki

Tsuda

Jaspiferals A–G, new cytotoxic isomalabaricane-type nortriterpenoids from Okinawan marine sponge Jaspis stellifera

Tetrahedron19965257455750

10.1016/0040-4020(96)00206-2

Zampella

D’Auria

Debitus

Menou

J.-L

New isomalabaricane derivatives from a new species of Jaspis sponge collected at the Vanuatu Islands

J Nat Prod200063943946

10.1021/np000088u

10924170

100

Bourguet-Kondracki

M-LA

Debitus

Guyot

New cytotoxic isomalabaricane-type sesterterpenes from the new Caledonian marine sponge Rhabdastrella globostellata

Tetrahedron Lett20004130873090

10.1016/S0040-4039(00)00345-2

101

Tang

Pei

Deng

Proksch

Lin

Jaspolides A–F, six new isomalabaricane-type terpenoids from the sponge Jaspis sp

Chem Pharm Bull20065448

10.1248/cpb.54.4

16394540

102

Tang

Deng

Proksch

Lin

Jaspolides G and H, unique bisisomalabaricanes from the Chinese marine sponge Jaspis sp

Tetrahedron Lett20074854435447

10.1016/j.tetlet.2007.06.003

103

Wei

S.-Y

Tang

S.-A

Lin

W.-H

Cui

J.-R

Antileukemic activity of jaspolide B, an isomalabaricance-type triterpene from marine sponge Jaspis sp. on human promyeloleukemic HL-60 cells

J Ch Pharm Sci2008171115 104

Wei

S.-Y

Tang

Sun

Cui

J.-R

Lin

W.-H

Induction of apoptosis accompanying with G₁ phase arrest and microtubule disassembly in human hepatoma cells by jaspolide B, a new isomalabaricane-type triterpene

Cancer Lett2008262114122

10.1016/j.canlet.2007.11.039

18191890

105

Cheng

Kobayashi

Nakamura

Ohizumi

Hirata

Sasaki

Penasterol, a novel antileukemic sterol from the Okinawan marine sponge Penares sp

J Chem Soc Perkin Trans I1988824032406 106

Shoji

Umeyama

Motoki

Arihara

Ishida

Nomoto

Kobayashi

Takei

Potent inhibitors of histamine release, two novel triterpenoids from the Okinawan marine sponge Penares incrustans

J Nat Prod19925516821685

10.1021/np50089a021

1282538

107

Carmely

Roll

Loya

Kashman

The structure of eryloside A, a new antitumor and antifungal 4-methylated steroidal glycoside from the sponge Erylus lendenfeldi

J Nat Prod198952167170

10.1021/np50061a022

2723665

108

D’Auria

Paloma

Minale

Riccio

Debitus

Structure characterization by two-dimensional NMR spectroscopy, of two marine triterpene oligosaccharides from a Pacific sponge of the genus

Erylus Tetrahedron199248491498

10.1016/S0040-4020(01)89011-6

109

Gulavita

Wright

Kelly-Borges

Longley

Yarwood

Sills

Eryloside E from an Atlantic sponge Erylus goffrilleri

Tetrahedron Lett19943542994302

10.1016/S0040-4039(00)73338-7

110

Stead

Hiscox

Robinson

Pike

Sidebottom

Roberts

Taylor

Wright

Pomponi

Langely

Eryoside F, a novel penasterol disaccharide possessing potent thrombin receptor antagonist activity

Bioorg Med Chem Lett200010661664

10.1016/S0960-894X(00)00063-9

10762048

111

Shin

Lee

H.-S

Woo

Rho

J.-R

Seo

Cho

Sim

New triterpenoid saponins from the sponge Erylus nobilis

J Nat Prod200164767771

10.1021/np010047d

11421740

112

Fouad

Al-Trabeen

Badran

Wray

Edrada

Proksch

Ebel

New steroidal saponins from the sponge Erylus lendenfeldi

ARKIVOC2004xiii1727 113

Antonov

Kalinovsky

Stonik

Afiyatullov

Aminin

Dmitrenok

Mollo

Cimino

Isolation and structures of erylosides from the Caribbean sponge Erylus formosus

J Nat Prod200770169178

10.1021/np060364q

17315957

114

Afiyatullov

Kalinovsky

Antonov

Ponomarenko

Dmitrenok

Aminin

Krasokhin

Nosova

Kisin

Isolation and structures of erylosides from the Caribbean sponge Erylus goffrilleri

J Nat Prod20077018711877

10.1021/np070319y

18004814

115

Jaspars

Crews

A triterpene tetrasaccharide, formoside, from the Caribbean Choristida sponge Erylus formosus

Tetrahedron Lett19943575017504

10.1016/S0040-4039(00)78328-6

116

Kubanek

Pawlik

Eve

Fenical

Triterpene glycosides defend the Caribbean reef sponge Erylus formosus from predatory fishes

Mar Ecol Prog Ser20002076977

10.3354/meps207069

117

Takada

Nakao

Matsunaga

van Soest

RWM

Fusetani

Nobiloside, a new neuraminidase inhibitory triterpenoidal saponin from the marine sponge Erylus nobilis

J Nat Prod200265411413

10.1021/np010480n

11908993

118

Okada

Matsunaga

van Soest

RWM

Fusetani

Sokodosides, steroid glycosides with an isopropyl side chain, from the marine sponge Erylus placenta

J Org Chem20067148844888

10.1021/jo060653j

16776517

119

Dasgupta

Pramanik

Mukhopadhyay

Oligosaccarides through reactivity tuning: convergent synthesis of the trisaccharides of the steroid glycoside sokodoside B isolated from marine sponge Erylus placenta

Tetrahedron2007631231012316

10.1016/j.tet.2007.09.072

120

Kitagawa

Kobayashi

Okamoto

Yoshikawa

Hamamoto

Structures of sarasinosides A₁, B₁, and C₁; new norlanostane-triterpenoid oligosaccharides from the Palauan marine sponge Asteropus sarasinosum

Chem Pharm Bull19873550365039

10.1248/cpb.35.5036

3451822

121

Schmitz

Ksebati

Gunasekera

Agarwal

Sarasinoside A₁: A saponin containing amino sugars isolated from a sponge

J Org Chem19885359415947

10.1021/jo00260a025

122

Kobayashi

Okamoto

Kitagawa

Marine natural products. XXVIII. The structures of sarasinosides A₁, A₂, A₃, B₁, B₂, B₃, C₁, C₂, and C₃, nine new norlanostane-triterpenoidal oligosaccharides from the Palauan marine sponge Asteropus sarasinosum

Chem Pharm Bull19913928672877

10.1248/cpb.39.2867

123

Espada

Jiménez

Rodríguez

Crews

Riguera

Sarasinosides D–G: four new triterpenoid saponins from the sponge Asteropus sarasinosum

Tetrahedron19924886858696

10.1016/S0040-4020(01)89444-8

124

Lee

H.-S

Seo

Cho

Rho

J.-R

Shin

Paul

New triterpenoid saponins from the sponge Melophlus isis

J Nat Prod200063915919

10.1021/np990589j

10924165

125

Dai

H.-F

Edrada

Ebel

Nimtz

Wray

Proksch

Norlanostane triterpenoidal saponins from the marine sponge Melophlus sarassinorum

J Nat Prod20056812311237

10.1021/np050152d

16124767

126

Kalinovsky

Antonov

Afiyatullov

Dmitrenok

Evtuschenko

Stonik

Mycaloside A, a new steroid oligoglycoside with an unprecedented structure from the Caribbean sponge Mycale laxissima

Tetrahedron Lett200243523525

10.1016/S0040-4039(01)02184-0

127

Antonov

Afiyatullov

Kalinovsky

Ponomarenko

Dmitrenok

Aminin

Agafonosa

Stonik

Mycalosides B–I, eight new spermostatic steroid oligoglycosides from the sponge Mycale laxissima

J Nat Prod20036610821088

10.1021/np0300030

12932129

128

Afiyatullov

Antonov

Kalinovsky

Dmitrenok

Two new steroid oligoglycosides from the Caribbean sponge Mycale laxissima

Nat Prod Commun2008315811586 129

Cafieri

Fattorusso

Taglialatela-Scafati

Ectyoplasides A–B – unique triterpene oligoglycosides from the Caribbean sponge Ectyoplasia ferox

Eur J Org Chem1999231238 130

Campagnuolo

Fattorusso

Taglialatela-Scafati

Feroxosides A–B, two norlanostane tetraglycosides from the Caribbean sponge Ectyoplasia ferox

Tetrahedron20015740494055

10.1016/S0040-4020(01)00287-3

131

Antonov

Kalinovsky

Stonik

Ulososide B, a new unusual norlanostanetriterpene glycoside and its genuine aglycone from the Madagascar sponge Ulosa sp

Tetrahedron Lett19983938073808

10.1016/S0040-4039(98)00589-9

132

Antonov

Kalinovskii

Dmitrenok

Stonik

New triterpene glycosides from Ulosa sp. sponge

Russ J Bioorg Chem200228183188

10.1023/A:1015700102890

133

Ryu

Choi

Lee

Hwang

K.-H

Lee

Jeong

Lee

Wondosterols A–C, three steroidal glycosides from a Korean marine two-sponge association

Tetrahedron1999551317113178

10.1016/S0040-4020(99)00810-8

134

Hirota

Takayama

Miyashiro

Ozaki

Ikegami

Structure of a novel steroidal saponin, pachastrelloside A, obtained from a marine sponge of the genus Pachastrella

Tetrahedron Lett19903133213324

10.1016/S0040-4039(00)89054-1

135

Proksch

Edrada

Ebel

Drugs from the sea: current status and microbiological applications

Appl Micobiol Biotechnol200259125134

10.1007/s00253-002-1006-8

136

Olivera

ω-Conotoxin MVIIA: from marine snail venom to analgesic drug

Drugs from the SeaFusetani

Basel

Karger, Switzerland

20007485 137

Mendola

Aquacultural production of bryostatin 1 and ecteinascidin 743

Drugs from the SeaFusetani

Karger

Basel, Switzerland

20007485 138

Fenical

Chemical studies of marine bacteria: developing a new resource

Chem Rev19939316731683

10.1021/cr00021a001

Figures Figure 1

Postulated biosynthetic relationship between all known Luffariella metabolites [12].

Figure 2

Proposed biogenetic transformation of jaspolides A–F (108–113) [101].

Figure 3

Postulated biogenetic pathway of jaspolides G (114) and H (115) [102].